Cartilage, fat pad, synovium and peripheral blood were collected from patients undergoing 10 arthroplasty. PLEC CpGs were analysed for mQTLs and allelic expression imbalance (AEI) 11 was performed. We focussed on previously reported mQTL clusters neighbouring cg19405177 12 and cg14598846. Plectin was knocked down in a mesenchymal stem cell (MSC) line using 13 CRISPR/Cas9 and cells phenotyped by RNA-sequencing. 14 15
Introduction

34
Osteoarthritis (OA) is an extremely common musculoskeletal disorder that is characterised by 35 focal loss of articular cartilage leading to chronic pain, disability, co-morbidities including 36 cardiovascular disease, and premature death [1] [2] [3] . OA is polygenic and in recent years over 90 37 genome-wide significant loci have been mapped in Europeans using high-density single 38 nucleotide polymorphism (SNP) arrays [4] [5] [6] [7] [8] [9] [10] . An overwhelming majority of the associated 39 expression imbalance (AEI) analysis (a complementary approach to standard eQTL analysis 17 ) 66 7 and anti-GAPDH (MAB374, Sigma Aldrich)/goat anti-mouse (P0447, Dako) as a loading 166 control. 167 168
RNA-sequencing 169
For each sample, the TruSeq Stranded mRNA library prep kit (Illumina) was used to prepare a 170 sequencing library from 1.5µg of total RNA. All samples were then sequenced to a depth of 171 ~52-71 million paired end reads on an Illumina NextSeq platform. Quality control of raw 172 sequencing reads was performed using FastQC (v0.11.7). All samples passed QC. Reads were 173 mapped to the hg38 (ENSEMBL version 91) reference genome using Salmon (v0.14.1) in 174 quasi-mapping mode on default settings 23 . All samples except one achieved alignment rates of 175 ~88%. Counts were summarised to gene level and imported into R using tximport 24 . Principle 176 component analysis (PCA) revealed the sample with the low alignment rate to be an outlier 177 and this was removed from further analysis, leaving four PLEC deletion and three controls. 178
Unwanted variation in the dataset was estimated using surrogate variable analysis (svaseq 25 ). 179
The number of surrogate variables was estimated at two and these were included into the model 180 for differential expression analysis. Differential expression analysis between deletion and 181 control samples was performed using the Wald test implemented in DESeq2 26 . The false 182 discovery rate (FDR) was controlled using the Benjamini-Hochberg procedure. Genes with an 183 FDR P<0.05 were considered significant. Gene set enrichment analysis (GSEA 27 ) was used to 184 discover overrepresented pathways in the set of up-and down-regulated genes. The full gene Figure 4B ). In fat pad, AEI was 253 observed in a majority of the patients, but this did not correlate with a particular allele (P=0.31; 254 Figure 4A ). 255
To emphasize the variability of AEI in tissues from the same patient, we next plotted 256 the data for those patients in whom we had studied fat pad and synovium (Supplementary 257 Figure 7 ). There were six such patients with clear variability in the G/A ratio between the two 258 tissues tested for most of these, with patients 5680 and 5725 demonstrating particularly clear 259 inter-tissue variability in the ratio; in both, the G allele is more highly expressed in fat pad but 260 more lowly expressed in synovium relative to the A allele. 261
The significant AEI in synovium was in the same direction that we had observed in 262 cartilage 16 , with the G allele of rs11783799, which marks the OA risk conferring A allele of
We next plotted the PLEC AEI data for the fat pad and synovium compound 267 heterozygotes against their individual methylation data. In fat pad, there was no evidence of a 268 significant correlation between methylation and AEI at cg19405177, cg14598846 or the 269 additional 10 CpGs measured (all P values >0.05; Supplementary Figure 8) . However, in 270 synovium, three of the CpGs correlated with AEI; CpG3 from the cg19405177 cluster 271 (P=0.049), and cg14598846 (P=0.039) and CpG2 (P=0.047) from the cg14598846 cluster 272 (Supplementary Figure 9) . These three CpGs had also shown meQTL activity in our previous 273 cartilage study 16 . For CpG3 from the cg19405177 cluster, the same direction of effect is seen 274 in cartilage and synovium, with increased methylation correlating with decreased AEI (the log2 275 AEI ratio moves towards zero with increasing methylation). However, for cg14598846 and 276
CpG2 from the cg14598846 cluster, the effects are in opposite directions between cartilage and 277 synovium; in cartilage, increased methylation correlated with decreased AEI whereas in 278 synovium, increased methylation correlated with increased AEI (the log2 AEI ratio moves 279 away from zero with increasing methylation). 280
In summary, the PLEC rs11780978 eQTL previously observed in cartilage also 281 operates in synovium. Furthermore, we observed correlations between PLEC expression and 282
CpG methylation in synovium. These meQTLs are shared with cartilage but are not necessarily 283 operating in the same manner. 284 285
Knock-down of PLEC and plectin elicits a response 286
Our previous data and the results generated here highlight that the OA risk conferring A allele 287 of rs11780978 correlates with decreased expression of PLEC in cartilage and synovium. We 288 modelled this effect by knocking-down plectin. We used an immortalised human MSC cell line 289 that is amenable to CRISPR-based editing 31 and transduced it to constitutively express Cas9. 290
We then generated a 26bp frame-shift deletion of PLEC exon 3, with four replicates for deletion 291 and four control replicates. The cells were cultured in monolayer for up to 14 days and the 292 deletion was confirmed by PCR and Sanger sequencing, whilst a near-total plectin knock-out 293 was observed by immunoblotting using an antibody that binds to the C-terminus of the protein 294 ( Figure 5A -C). The isolated RNA was then subjected to next-generation mRNA sequencing. 295
This revealed alternate splicing occurring in PLEC in the deletion samples, with exon 3 being 296 completely skipped in a subset of transcripts ( Figure 5D ). No exon skipping was seen in the 297 control samples. The level of PLEC mRNA was 26% lower in the deletion samples compared 298 to the controls (log2 fold change of -0.44; FDR P=0.001; Supplementary Table 2 ). In summary, 299 this data implies that the Cas9-mediated deletion impacted on the transcription of PLEC and 300 on the translation of PLEC mRNA into plectin. 301
We next assessed the effect of this plectin knock-down on the transcriptome. In addition 302
to PLEC, the deletion had a significant effect (FDR P<0.05) on the expression of 269 genes 303 ( Figure 6A The correlation between genotype and methylation was determined using adjusted r 2 values 518 calculated using a standard least squares linear regression model and expressed as a percentage. 519
Data analysis was performed using SAS JMP Statistical Data Visualization Software and heat 520 maps produced in PRISM. Patients contributing data to the cg19405177 cluster 1: cartilage, 521 n=81; fat pad, n=39; synovium, n=64; blood, n=43. Patients contributing data to the 522 cg14598846 cluster: cartilage, n=103; fat pad, n=68; synovium, n=79; blood, n=54. 523 
